NM_022124.6(CDH23):c.10027G>A (p.Val3343Met) AND Usher syndrome type 1

Clinical significance:Uncertain significance (Last evaluated: Sep 16, 2020)

Review status:(0/4) 0 stars out of maximum of 4 stars

no assertion criteria provided

Based on:
1 submission [Details]
Record status:
current
Accession:
RCV001271960.1

Allele description [Variation Report for NM_022124.6(CDH23):c.10027G>A (p.Val3343Met)]

NM_022124.6(CDH23):c.10027G>A (p.Val3343Met)

Gene:
CDH23:cadherin related 23 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q22.1
Genomic location:
Preferred name:
NM_022124.6(CDH23):c.10027G>A (p.Val3343Met)
HGVS:
  • NC_000010.11:g.71815240G>A
  • NG_008835.1:g.423294G>A
  • NG_009301.1:g.41086C>T
  • NM_001171933.1:c.3307G>A
  • NM_001171934.1:c.3202G>A
  • NM_001171935.1:c.718G>A
  • NM_001171936.1:c.613G>A
  • NM_022124.6:c.10027G>AMANE SELECT
  • NP_001165404.1:p.Val1103Met
  • NP_001165405.1:p.Val1068Met
  • NP_001165406.1:p.Val240Met
  • NP_001165407.1:p.Val205Met
  • NP_071407.4:p.Val3343Met
  • NC_000010.10:g.73574997G>A
  • NM_022124.5:c.10027G>A
Protein change:
V1068M
Links:
dbSNP: rs756425157
NCBI 1000 Genomes Browser:
rs756425157
Molecular consequence:
  • NM_001171933.1:c.3307G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171934.1:c.3202G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171935.1:c.718G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171936.1:c.613G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_022124.6:c.10027G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Usher syndrome type 1 (USH1)
Synonyms:
Usher syndrome, type I, French variety; Retinitis pigmentosa and congenital deafness
Identifiers:
MONDO: MONDO:0010168; MedGen: C1568247; Orphanet: 231169; Orphanet: 886; OMIM: 276900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001453535Natera, Inc.no assertion criteria providedUncertain significance
(Sep 16, 2020)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV001453535.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 27, 2021

Support Center